Search research articles
Contact Us
Filters
Showing results (421-430 of 434) with videos related to
Page
of 44
Sort By:
Journal of the National Cancer Institute
|
January 11, 2020
The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design
Keith T Flaherty, Robert Gray, Alice Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 8, 2025
Genomics Define Malignant Transformation in Myeloma Precursor Conditions
Francesco Maura, P Leif Bergsagel, Bachisio Ziccheddu, et al.
Blood Cancer Journal
|
March 26, 2026
Linvoseltamab versus real-world International Myeloma Working Group standard-of-care in triple-class exposed relapsed/refractory multiple myeloma
Shaji Kumar, Sundar Jagannath, Katja C Weisel, et al.
Research Square
|
June 12, 2025
Enhanced Risk Stratification of Smoldering Multiple Myeloma with Dynamic Biomarkers: A Multinational, Multicenter Study including 2,270 Participants (PANGEA 2.0)
Floris Chabrun, Daniel Schwartz, Susanna Gentile, et al.
Leukemia
|
April 22, 2020
Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era
Binod Dhakal, Sagar Patel, Saulius Girnius, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 9, 2025
International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma
Hervé Avet-Loiseau, Faith E Davies, Mehmet K Samur, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 20, 2016
Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma
Robert F Cornell, Anita D'Souza, Adetola A Kassim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 10, 2013
Salvage second hematopoietic cell transplantation in myeloma
Laura C Michaelis, Ayman Saad, Xiaobo Zhong, et al.
Nature Medicine
|
March 25, 2026
Enhanced dynamic risk stratification of smoldering multiple myeloma
Floris Chabrun, Daniel E Schwartz, Susanna Gentile, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 3, 2015
American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma
Sergio Giralt, Laurent Garderet, Brian Durie, et al.
Page
of 44
Search research articles
Search
Showing results (421-430 of 434) with videos related to
Sort By:
Page
of 44
Journal of the National Cancer Institute
|
January 11, 2020
The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design
Keith T Flaherty, Robert Gray, Alice Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 8, 2025
Genomics Define Malignant Transformation in Myeloma Precursor Conditions
Francesco Maura, P Leif Bergsagel, Bachisio Ziccheddu, et al.
Blood Cancer Journal
|
March 26, 2026
Linvoseltamab versus real-world International Myeloma Working Group standard-of-care in triple-class exposed relapsed/refractory multiple myeloma
Shaji Kumar, Sundar Jagannath, Katja C Weisel, et al.
Research Square
|
June 12, 2025
Enhanced Risk Stratification of Smoldering Multiple Myeloma with Dynamic Biomarkers: A Multinational, Multicenter Study including 2,270 Participants (PANGEA 2.0)
Floris Chabrun, Daniel Schwartz, Susanna Gentile, et al.
Leukemia
|
April 22, 2020
Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era
Binod Dhakal, Sagar Patel, Saulius Girnius, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 9, 2025
International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma
Hervé Avet-Loiseau, Faith E Davies, Mehmet K Samur, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 20, 2016
Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma
Robert F Cornell, Anita D'Souza, Adetola A Kassim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 10, 2013
Salvage second hematopoietic cell transplantation in myeloma
Laura C Michaelis, Ayman Saad, Xiaobo Zhong, et al.
Nature Medicine
|
March 25, 2026
Enhanced dynamic risk stratification of smoldering multiple myeloma
Floris Chabrun, Daniel E Schwartz, Susanna Gentile, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 3, 2015
American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma
Sergio Giralt, Laurent Garderet, Brian Durie, et al.
Page
of 44